151 related articles for article (PubMed ID: 9688317)
21. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide.
Willenborg DO; Fordham SA; Staykova MA; Ramshaw IA; Cowden WB
J Immunol; 1999 Nov; 163(10):5278-86. PubMed ID: 10553050
[TBL] [Abstract][Full Text] [Related]
22. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.
Happ MP; Wettstein P; Dietzschold B; Heber-Katz E
J Immunol; 1988 Sep; 141(5):1489-94. PubMed ID: 2457618
[TBL] [Abstract][Full Text] [Related]
23. Exposure to a dysfunctional glucocorticoid receptor from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via nitric oxide-induced immunosuppression.
Marchetti B; Morale MC; Brouwer J; Tirolo C; Testa N; Caniglia S; Barden N; Amor S; Smith PA; Dijkstra CD
J Immunol; 2002 Jun; 168(11):5848-59. PubMed ID: 12023389
[TBL] [Abstract][Full Text] [Related]
24. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes.
Bouwer HG; Hinrichs DJ
J Neuroimmunol; 1994 Oct; 54(1-2):87-98. PubMed ID: 7523447
[TBL] [Abstract][Full Text] [Related]
25. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison.
Strejan GH; St Louis J
Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689
[TBL] [Abstract][Full Text] [Related]
26. Rat splenocytes inhibit antigen-specific lymphocyte proliferation through a reactive nitrogen intermediate (RNI)-dependent mechanism and exhibit increased RNI production in response to IFN-gamma.
Stein CS; Strejan GH
Cell Immunol; 1993 Sep; 150(2):281-97. PubMed ID: 8370073
[TBL] [Abstract][Full Text] [Related]
27. Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin-12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis.
Yang JS; Xu LY; Huang YM; Van Der Meide PH; Link H; Xiao BG
Immunology; 2000 Nov; 101(3):397-403. PubMed ID: 11106944
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats.
Lorentzen JC; Andersson M; Issazadeh S; Dahlman I; Luthman H; Weissert R; Olsson T
J Neuroimmunol; 1997 Dec; 80(1-2):31-7. PubMed ID: 9413257
[TBL] [Abstract][Full Text] [Related]
29. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase.
Zhao W; Tilton RG; Corbett JA; McDaniel ML; Misko TP; Williamson JR; Cross AH; Hickey WF
J Neuroimmunol; 1996 Feb; 64(2):123-33. PubMed ID: 8632054
[TBL] [Abstract][Full Text] [Related]
30. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
[TBL] [Abstract][Full Text] [Related]
31. The role of regulatory T cells in Lewis rats resistant to EAE.
Sun D; Wilson DB; Cao L; Whitaker JN
J Neuroimmunol; 1998 Jan; 81(1-2):177-83. PubMed ID: 9521620
[TBL] [Abstract][Full Text] [Related]
32. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin.
Stanislaus R; Gilg AG; Singh AK; Singh I
Neurosci Lett; 2002 Nov; 333(3):167-70. PubMed ID: 12429374
[TBL] [Abstract][Full Text] [Related]
34. Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens.
Stein CS; St Louis J; Gilbert JJ; Strejan GH
J Neuroimmunol; 1990 Jul; 28(2):119-30. PubMed ID: 1694533
[TBL] [Abstract][Full Text] [Related]
35. Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis.
McDonald AH; Swanborg RH
J Immunol; 1988 Feb; 140(4):1132-8. PubMed ID: 2963860
[TBL] [Abstract][Full Text] [Related]
36. Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1.
del Rey A; Klusman I; Besedovsky HO
Am J Physiol; 1998 Oct; 275(4):R1146-51. PubMed ID: 9756545
[TBL] [Abstract][Full Text] [Related]
37. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
Saoudi A; Simmonds S; Huitinga I; Mason D
J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
[TBL] [Abstract][Full Text] [Related]
38. Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalitis in aged rats.
Ludowyk PA; Hughes W; Hugh A; Willenborg DO; Rockett KA; Parish CR
J Neuroimmunol; 1993; 48(2):121-34. PubMed ID: 7693751
[TBL] [Abstract][Full Text] [Related]
39. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
[TBL] [Abstract][Full Text] [Related]
40. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
Whitacre CC; Gienapp IE; Orosz CG; Bitar DM
J Immunol; 1991 Oct; 147(7):2155-63. PubMed ID: 1717550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
